SIRT6 and neoplasm: Their findings also support our results, wherein we observed that in the tumour setting, SIRT6 over‐expression inhibited WNT4 expression in the skeletal muscle and downregulated circulating levels of WNT4, which might have contributed to maintain plasma insulin levels in Tu‐Sk.T6Tg mice.